| New anticancer agents: recent developments in tumor therapy R Ali, Z Mirza, GMD Ashraf, MA Kamal, SA Ansari, GA Damanhouri, ... Anticancer research 32 (7), 2999-3005, 2012 | 206 | 2012 |
| Significance of anti-HBc screening of blood donors & its association with occult hepatitis B virus infection: Implications for blood transfusion M Asim, R Ali, LA Khan, SA Husain, R Singla, P Kar Indian Journal of Medical Research 132 (3), 312-317, 2010 | 85 | 2010 |
| CD4+ CD25+ T regs with acetylated FoxP3 are associated with immune suppression in human leprosy S Kumar, RA Naqvi, R Ali, R Rani, N Khanna, DN Rao Molecular immunology 56 (4), 513-520, 2013 | 62 | 2013 |
| Molecular linkages between diabetes and Alzheimer's disease: current scenario and future prospects T A Dar, I A Sheikh, S A Ganie, R Ali, L R Singh, S Hua Gan, M A Kamal, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014 | 49 | 2014 |
| Emerging role of angiotensin AT2 receptor in anti-inflammation: an update SN Patel, N Fatima, R Ali, T Hussain Current pharmaceutical design 26 (4), 492-500, 2020 | 36 | 2020 |
| IL-10 production from dendritic cells is associated with DC SIGN in human leprosy S Kumar, RA Naqvi, AA Bhat, R Rani, R Ali, A Agnihotri, N Khanna, ... Immunobiology 218 (12), 1488-1496, 2013 | 32 | 2013 |
| FoxP3 provides competitive fitness to CD4+CD25+ T cells in leprosy patients via transcriptional regulation S Kumar, RA Naqvi, R Ali, R Rani, N Khanna, DN Rao European journal of immunology 44 (2), 431-439, 2014 | 31 | 2014 |
| Generation of β cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice J Babad, G Mukherjee, A Follenzi, R Ali, BO Roep, LD Shultz, ... Clinical & Experimental Immunology 179 (3), 398-413, 2015 | 28 | 2015 |
| New peptide based therapeutic approaches R Ali, R Rani, S Kumar Advances in Protein Chemistry. Jeddah: OMICS Group eBooks, 2013 | 23 | 2013 |
| Multiple Antigen Peptide Containing B and T Cell Epitopes of F1 Antigen of Yersinia pestis Showed Enhanced Th1 Immune Response in Murine Model R Ali, RA Naqvi, S Kumar, AA Bhat, DN Rao Scandinavian Journal of Immunology 77 (5), 361-371, 2013 | 22 | 2013 |
| HLA-B* 39: 06 efficiently mediates type 1 diabetes in a mouse model incorporating reduced thymic insulin expression J Schloss, R Ali, JJ Racine, HD Chapman, DV Serreze, TP DiLorenzo The Journal of Immunology 200 (10), 3353-3363, 2018 | 18 | 2018 |
| Angiotensin type 2 receptor activation limits kidney injury during the early phase and induces Treg cells during the late phase of renal ischemia R Ali, S Patel, T Hussain American Journal of Physiology-Renal Physiology 320 (5), F814-F825, 2021 | 17 | 2021 |
| CD4+TCRγδ+FoxP3+ cells: An unidentified population of immunosuppressive cells towards disease progression leprosy patients M Tarique, RA Naqvi, R Ali, N Khanna, DN Rao Experimental Dermatology 26 (10), 946-948, 2017 | 16 | 2017 |
| Induction of Cell-Mediated Immune Responses to Peptide Antigens of P. vivax in Microparticles Using Intranasal Immunization AA Bhat, RK Seth, S Kumar, R Ali, T Mohan, S Biswas, DN Rao Immunological investigations 39 (4-5), 483-499, 2010 | 16 | 2010 |
| B and T cell epitope mapping and study the humoral and cell mediated immune response to B–T constructs of YscF antigen of Yersinia pestis R Ali, S Kumar, RA Naqvi, DN Rao Comparative Immunology, Microbiology and Infectious Diseases 36 (4), 365-378, 2013 | 15 | 2013 |
| An overview on potential neuroprotective compounds for management of Alzheimer's disease I Ahmed Sheikh, R Ali, T A Dar, M Amjad Kamal CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2012 | 15 | 2012 |
| Cell-mediated immune response to epitopic MAP (multiple antigen peptide) construct of LcrV antigen of Yersinia pestis in murine model RK Shreewastav, R Ali, JB Uppada, DN Rao Cellular immunology 278 (1-2), 55-62, 2012 | 15 | 2012 |
| Multiple antigen peptide consisting of B-and T-cell epitopes of F1 antigen of Y. pestis showed enhanced humoral and mucosal immune response in different strains of mice R Ali, S Kumar, RA Naqvi, IA Sheikh, DN Rao International immunopharmacology 15 (1), 97-105, 2013 | 14 | 2013 |
| Genetically modified human CD4+ T cells can be evaluated in vivo without lethal graft‐versus‐host disease R Ali, J Babad, A Follenzi, JA Gebe, MA Brehm, GT Nepom, LD Shultz, ... Immunology 148 (4), 339-351, 2016 | 10 | 2016 |
| Comparative Review of Decade's Research on Cholinesterase Inhibition R Ali, IA Sheikha, NR Jabirb, MA Kamal American Journal of Neuroprotection and Neuroregeneration 4 (2), 136-144, 2012 | 10 | 2012 |
Prof. Mohammad A KamalKing Fahd Medical Research CenterVerified email at kau.edu.sa
